| Timothy D Shafman, MD | |
|
50 Maude St, Providence, RI 02908-4325 | |
| (401) 456-2690 | |
| (401) 456-6540 |
| Full Name | Timothy D Shafman |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 35 Years |
| Location | 50 Maude St, Providence, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366424533 | NPI | - | NPPES |
| 822225 | Other | RI | USA MNGD. CR. PROV. # |
| AA15549 | Other | RI | HARV. PILG. PROVIDER # |
| 008002447 | Medicaid | CT | |
| P01798845 | Other | FL | CLEAR HEALTH ALLIANCE |
| P994555 | Other | FL | FREEDOM |
| 010011456RI01 | Other | CT | ANTHEM BCBS CT PROV. # |
| 412134 | Other | RI | BCBS RI - BLUECHIP PROV # |
| 015965200 | Medicaid | FL | |
| 29025-8 | Other | RI | BCBS OF RI PROVIDER # |
| 5524206 | Other | RI | AETNA REF/CERT # |
| J30652 | Other | MA | BCBS OF MASS PROVIDER # |
| P01107077 | Other | MA | RAILROAD MCR |
| 3133087 | Medicaid | MA | |
| 98985603 | Other | MA | NETWORK HEALTH |
| P00762779 | Other | RI | RAILROAD MEDICARE - RADIOSURGERY CENTER OF RI |
| 30348 | Other | RI | NEIGHBR. HLTH PL. PROV. # |
| 3701804 | Other | RI | AETNA PROVIDER NUMBER |
| 387766 | Other | FL | AVMED |
| 42700 | Other | RI | HEALTH NEW ENGLAND |
| 7057190 | Medicaid | RI | |
| P00693330 | Other | RI | RAIL ROAD MEDICARE |
| P01580612 | Other | FL | RR MEDICARE |
| 1493289 | Other | FL | CIGNA |
| 1493289 | Other | RI | CIGNA PROVIDER NUMBER |
| 3133087 | Other | MA | MASS HEALTH PROVIDER # |
| 5524206 | Other | FL | AETNA |
| ZS4X3 | Other | FL | BCBS |
| 079255 | Other | RI | TUFTS HLTH PLN. PROV. # |
| P00762754 | Other | MA | RAILROAD MEDICARE - CMCCC |
| P971651 | Other | FL | OPTIMUM |
| Facility Name | Location | Facility Type |
|---|---|---|
| Roger Williams Medical Center | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Roger Williams Radiation Therapy Llc | 3476658188 | 3 |
| Southern New England Regional Cancer Center, Llc | 8820049752 | 3 |
News Archive
Those ubiquitous wires connecting listeners to you-name-the-sounds from invisible MP3 players - whether of Bach, Miles Davis or, more likely today, Lady Gaga - only hint at music's effect on the soul throughout the ages.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
Cell Therapeutics, Inc. today announced the successful closing of its previously announced sale of $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The sold securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock.
The HEALTHY FUTURES (Health, environmental change and adaptive capacity) and QWeCI (Quantifying Quantifying Weather and Climate Impacts on Health in Developing Countries) projects will jointly host a symposium on links between climate and vector-borne diseases (VBDs) at the upcoming 4th East African Community Health and Scientific Conference, scheduled for 27th-29th March 2013 in Kigali, Rwanda.
New techniques proposed by an international research team, could mean the mass production of meat reared was not on the farm, but in the laboratory.
› Verified 4 days ago
| Entity Name | Southern New England Regional Cancer Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134109697 PECOS PAC ID: 8820049752 Enrollment ID: O20050208000494 |
News Archive
Those ubiquitous wires connecting listeners to you-name-the-sounds from invisible MP3 players - whether of Bach, Miles Davis or, more likely today, Lady Gaga - only hint at music's effect on the soul throughout the ages.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
Cell Therapeutics, Inc. today announced the successful closing of its previously announced sale of $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The sold securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock.
The HEALTHY FUTURES (Health, environmental change and adaptive capacity) and QWeCI (Quantifying Quantifying Weather and Climate Impacts on Health in Developing Countries) projects will jointly host a symposium on links between climate and vector-borne diseases (VBDs) at the upcoming 4th East African Community Health and Scientific Conference, scheduled for 27th-29th March 2013 in Kigali, Rwanda.
New techniques proposed by an international research team, could mean the mass production of meat reared was not on the farm, but in the laboratory.
› Verified 4 days ago
| Entity Name | Roger Williams Radiation Therapy Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013078450 PECOS PAC ID: 3476658188 Enrollment ID: O20070424000663 |
News Archive
Those ubiquitous wires connecting listeners to you-name-the-sounds from invisible MP3 players - whether of Bach, Miles Davis or, more likely today, Lady Gaga - only hint at music's effect on the soul throughout the ages.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
Cell Therapeutics, Inc. today announced the successful closing of its previously announced sale of $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The sold securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock.
The HEALTHY FUTURES (Health, environmental change and adaptive capacity) and QWeCI (Quantifying Quantifying Weather and Climate Impacts on Health in Developing Countries) projects will jointly host a symposium on links between climate and vector-borne diseases (VBDs) at the upcoming 4th East African Community Health and Scientific Conference, scheduled for 27th-29th March 2013 in Kigali, Rwanda.
New techniques proposed by an international research team, could mean the mass production of meat reared was not on the farm, but in the laboratory.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy D Shafman, MD 2234 Colonial Blvd, Fort Myers, FL 33907-1412 Ph: (239) 931-7342 | Timothy D Shafman, MD 50 Maude St, Providence, RI 02908-4325 Ph: (401) 456-2690 |
News Archive
Those ubiquitous wires connecting listeners to you-name-the-sounds from invisible MP3 players - whether of Bach, Miles Davis or, more likely today, Lady Gaga - only hint at music's effect on the soul throughout the ages.
GENFIT, a biopharmaceutical company at the forefront of drug discovery and development, focusing on the early diagnosis and preventive treatment of cardiometabolic and associated disorders, today announces new pre-clinical data demonstrating the inhibitory effects of GFT505 on the proliferation of cancer cells of different origins.
Cell Therapeutics, Inc. today announced the successful closing of its previously announced sale of $4.06 million of securities to an accredited investor in a private offering pursuant to Section 4(2) of the Securities Act of 1933, as amended. The sold securities consist of 4,060 shares of Series 6 preferred stock, no par value per share, together with warrants to purchase an aggregate of 5.8 million shares of common stock.
The HEALTHY FUTURES (Health, environmental change and adaptive capacity) and QWeCI (Quantifying Quantifying Weather and Climate Impacts on Health in Developing Countries) projects will jointly host a symposium on links between climate and vector-borne diseases (VBDs) at the upcoming 4th East African Community Health and Scientific Conference, scheduled for 27th-29th March 2013 in Kigali, Rwanda.
New techniques proposed by an international research team, could mean the mass production of meat reared was not on the farm, but in the laboratory.
› Verified 4 days ago
Lars Stangenberg, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 2 Dudley St, Suite 470, Providence, RI 02905 Phone: 401-553-8318 Fax: 401-868-2307 | |
Kara Lynne Leonard, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Rih Radiation Oncology, Providence, RI 02903 Phone: 401-444-8311 Fax: 401-444-5335 | |
Michael Low Cardenas, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 825 N Main St, Providence, RI 02904 Phone: 774-279-0884 | |
Earle O Assanah, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5174 | |
Sarah-kim Shields, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Radiology, Providence, RI 02903 Phone: 401-444-2133 Fax: 401-444-5017 | |
Sean O'neill, MD Radiology Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5127 Fax: 401-444-3056 | |
John Scaringi, MD Radiology Medicare: Medicare Enrolled Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-4000 |